Stockreport

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF – Evidence for Neuroprotective Activity of Vidofludimus Calcium from Phase 2 CALLIPER Interim Analysis, Consistent Across the Entire Progressive Multiple Sclerosis Popu [Read more]